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2Chalmers comments that "Hemilä accuses us of assuming that if the volunteers guessed correctly which
group they were in that means that they knew, which is obviously not the case." In the Methods section
of Karlowski's Journal of the American Medical Association (JAMA) paper [1] it is stated that "a
questionnaire was submitted to each of the participants asking them to guess which substance they had
been taking. The results of the questionnaire (Table 2) made it mandatory to perform the analyses both in
toto as well as according to the participants' impression as to what they were taking" (italics mine). In
Table 2 of the Karlowski paper there are 40 and 39 subjects who correctly "suspected" their drug was
ascorbic acid or placebo, respectively [1]. Table 4 of the same article is titled "Distribution of colds
according to knowledge of capsule contents" (italics mine) and in this table it is stated that the same 40
and 39 subjects "knew" whether they were being administered ascorbic acid or placebo [1]. However, the
authors did not say how they became convinced in between Tables 2 and 4 that a subject actually knew
the treatment instead of merely suspecting. Table 6 lists the results for the subgroup of "unblinded"
subjects [1]. The term "unblinded" indicates that the subjects genuinely knew their treatment, whereas
the Methods section implies that these are actually subjects that gave a correct answer when asked to
"guess" which capsules they had been taking. In their conclusion the authors stated that [1]: "an
association between severity and duration of symptoms and knowledge of the medication taken seems to
have been clearly established" (italics mine). Thus the JAMA paper itself suggests that the correct
answers on the questionnaire were interpreted by the authors as actual knowledge of the treatment,
although a great proportion of the correct answers could have been due to correct guesses, as pointed out
in my paper.
 Chalmers claims that no conclusions on the dose-response relationship can be drawn from their study.
This statement seems inconsistent with the JAMA paper [1], in which the authors commented that
"volunteers taking placebo had colds of a mean duration of 7.14 days, while those taking 3 gm of
ascorbic acid had colds of a mean duration of 6.59 days and those taking 6 gm had colds of a mean
duration of 5.92 days. Thus, each 3-gm increment of ascorbic acid would appear to shorten the mean
duration of a cold by approximately half a day." The authors thus explicitly paid attention to the apparent
dose dependence, and it seems that they implicitly considered the possibility that larger doses might have
produced still greater effects. They nonetheless discarded the notion of dose dependence since they
concluded from their subgroup analysis that the observed differences were due to the placebo effect. If
the placebo effect interpretation is to be rejected, as I suggest in my paper, the apparent dose dependence
becomes a relevant issue again.
 There are numerous popular misconceptions about vitamins and about nutrition in general.
Nevertheless, the effect of vitamin C on colds has been of great interest in the academic community also.
Kleijnen et al. [2,3] carried out a thorough literature search and  found 61 controlled trials related to the
question of whether vitamin C has effects on the common cold. In the early 1970s Pauling concluded that
?1 g/day prevents and alleviates colds [4], and since then 21 placebo-controlled studies using regular
high-dose vitamin C supplementation (?1 g/day) have been published [5]. These studies may be
considered as tests of Pauling's hypothesis. It is clear that Pauling overestimated the effects of vitamin C
supplementation. The incidence of the common cold has not been markedly reduced in subjects
administered vitamin C [5]. The effect on symptoms has been less than Pauling supposed, even though
consistent benefit has been observed [5]. Still, vitamin C is safe even at high levels of intake [6] and
costs few cents per gram, so that even a modest effect may be of practical importance. It would seem
worthwhile to investigate in detail what the quantitative effects on colds are, and which groups of people
would benefit most. The clinical significance can then be estimated more accurately. I do not think that
either popular misconceptions or Pauling's overoptimism should hamper such investigation.
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